The DOI matches its Crossref record.
18F-FLT PET/CT for Early Response Monitoring and Dose Escalation in Oropharyngeal Tumors
Open accessAbstract
UNLABELLED: Accelerated tumor cell proliferation is an important mechanism adversely affecting therapeutic outcome in head and neck cancer. 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) is a PET tracer to noninvasively image tumor cell proliferation. The aims of this study were to monitor early tumor response based on repetitive (18)F-FLT PET/CT scans and to identify subvolumes with high proliferative activity eligible for dose escalation. METHODS: Ten patients with oropharyngeal tumors underwent an (18)F-FLT PET/CT scan before and twice during radiotherapy. The primary tumor and metastatic lymph nodes (gross tumor volume, or GTV) were delineated on CT (GTV(CT)) and after segmentation of the PET signal using the 50% isocontour of the maximum signal intensity or an adaptive threshold based on the signal-to-background ratio (GTV(SBR)). GTVs were calculated, and similarity between GTV(CT) and GTV(SBR) was assessed. Within GTV(SBR), the maximum and mean standardized uptake value (SUV(max) and SUV(mean), respectively) was calculated. Within GTV(CT), tumor subvolumes with high proliferative activity based on the 80% isocontour (GTV(80%)) were identified for radiotherapy planning with dose escalation. RESULTS: The GTV(CT) decreased significantly in the fourth week but not in the initial phase of treatment. SUV(max) and SUV(mean) decreased significantly as early as 1 wk after therapy initiation and even further before the fourth week of treatment. For the primary tumor, the average (+/-SD) SUV(mean) of the GTV(SBR) was 4.7 +/- 1.6, 2.0 +/- 0.9, and 1.3 +/- 0.2 for the consecutive scans (P < 0.0001). The similarity between GTV(CT) and GTV(SBR) decreased during treatment, indicating an enlargement of GTV(SBR) outside GTV(CT) caused by the increasing difficulty of segmenting tracer uptake in the tumor from the background and by proliferative activity in the nearby tonsillar tissue. GTV(80%) was successfully identified in all primary tumors and metastatic lymph nodes, and dose escalation based on the GTV(80%) was demonstrated to be technically feasible. CONCLUSION: (18)F-FLT is a promising PET tracer for imaging tumor cell proliferation in head and neck carcinomas. Signal changes in (18)F-FLT PET precede volumetric tumor response and are therefore suitable for early response assessment. Definition of tumor subvolumes with high proliferative activity and dose escalation to these regions are technically feasible.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Molecular Imaging–Based Dose Painting: A Novel Paradigm for Radiation Therapy Prescription
Bentzen, S. M., & Gregoire, V. (2011) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2010.10.001 · Cited by 307
PET/CT imaging in cancer: current applications and future directions
Farwell, M. D., Pryma, D. A., & Mankoff, D. A. (2014) · Cancer · doi:10.1002/cncr.28860 · Cited by 230
Fonti, R., Conson, M., & Del Vecchio, S. (2019) · Seminars in Oncology · doi:10.1053/j.seminoncol.2019.07.001 · Cited by 153
Metadata
- Authors
- Troost, E. G. C., Bussink, J., Hoffmann, A. L., Boerman, O. C., Oyen, W. J. G., & Kaanders, J. H. A. M.
- Venue
- Journal of Nuclear Medicine
- Publisher
- Society of Nuclear Medicine
- Published
- 2010-05-19
- Volume
- 51
- Issue
- 6
- Pages
- 866-874
- ISSN
- 0161-5505 (ISSN-L)
- 2159-662X
- OpenAlex
- W2103780528
- Cited by
- 158
- References
- 0
- FWCI
- 13.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 18F-FLT PET/CT for Early Response Monitoring and Dose Escalation in Oropharyngeal Tumors. https://app.cochat.ai/papers/10.2967/jnumed.109.069310
- The paper
- Troost, E. G. C., Bussink, J., Hoffmann, A. L., Boerman, O. C., Oyen, W. J. G., & Kaanders, J. H. A. M. (2010). 18F-FLT PET/CT for Early Response Monitoring and Dose Escalation in Oropharyngeal Tumors. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.109.069310
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.